Gemma Collins' weight-loss drug Instagram post banned

---

Gemma Collins, a TV personality, recently found herself in hot water after posting an Instagram advertisement for a weight-loss drug and app that has since been banned. The post in question stated, “I’m starting this year two sizes down, thanks to Yazen’s weight loss app and medication”, a direct violation of regulations against advertising prescription-only weight loss drugs. The Advertising Standards Authority (ASA) cracked down on this specific post, along with eight others, resulting in their banishment.

Yazen, a Swedish digital healthcare brand, came under scrutiny for its doctor-supervised weight-loss program that combines prescription medications with lifestyle coaching. Gemma Collins shared a video advert for Yazen on her Instagram account on January 6th, where she discussed how the brand had helped her without directly endorsing any specific weight-loss medication. Despite this, the ASA determined that the advert made references that breached their code, leading to the ban.

In addition to Gemma Collins’ post, eight other advertisements promoting prescription-only weight-loss medications to the public were also banned. These adverts included Meta ads for CheqUp Health and HealthExpress.co.uk, as well as Google search ads for Juniper UK and Phlo Clinic, among others. The ASA consulted with the Medicines and Healthcare products Regulatory Agency, which expressed concerns about consumers being influenced to request prescription weight-loss medications as a result of these advertisements, ultimately leading to their prohibition.

Moving forward, none of the banned adverts will be permitted to appear in their current forms, as decreed by the ASA. Gemma Collins, along with the other advertisers, have been warned against promoting prescription-only weight-loss drugs to the public, emphasizing the importance of adhering to advertising regulations

Read the full article from The BBC here: Read More

---